CPI SHIPPING ENDOTAK 70/PRX IMPLANTABLE DEFIBRILLATOR SYSTEM
This article was originally published in The Gray Sheet
Executive Summary
CPI SHIPPING ENDOTAK 70/PRX IMPLANTABLE DEFIBRILLATOR SYSTEM following FDA approval on Aug. 5 of the Endotak 70 transvenous lead for use with the company's approved Ventak AICD automatic implantable cardioverter defibrillators. Approval of the lead makes Cardiac Pacemakers, Inc. the second company, behind Medtronic, to bring to the U.S. market a tiered-therapy defibrillator/transvenous lead combination. CPI launched the Ventak PRx implantable pacemaker/cardioverter/defibrillator in June ("The Gray Sheet" June 20, p. 18).
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.